Latest News & Features
Americas
Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools. 20 November 2018
Big Pharma
The UK has an excellent opportunity to adopt laws on supplementary protection certificates that will provide a “clearer” set of legislation post-Brexit, said French lawyer Marianne Schaffner, partner at Dentons. 19 November 2018
Big Pharma
The EU General Court handed a victory to Merck KGaA late last week, after rejecting a Swiss company’s trademark appeal. 19 November 2018
Big Pharma
While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR. 16 November 2018
Big Pharma
Supplementary protection certificates are hugely important to MSD’s business, according to Elena Böhles, assistant counsel at the pharmaceutical company, based in Hertfordshire, UK. 16 November 2018
Asia-Pacific
Last year, for the first time in European Patent Office history, a Chinese company filed the most European patent applications, making an “impressive statement” on what companies in the country are doing, according to Peter Albrecht. 15 November 2018
Americas
The speed of technological advancements in the life sciences industry is forcing patent lawyers to consider whether the norms they’re used to dealing with in the profession still apply. 15 November 2018
Big Pharma
The UK Supreme Court’s decision in Warner-Lambert v Actavis is disappointing for pharmaceutical innovators, and enforcing second medical use patents may now be more challenging, lawyers have told LSIPR. 15 November 2018
Big Pharma
The UK Supreme Court today dismissed Warner-Lambert’s appeal in its pregabalin patent dispute with Actavis, while clarifying the role of plausibility in the sufficiency of patent applications. 14 November 2018
Americas
Quinn Emanuel Urquhart & Sullivan has hired IP life sciences partner Colleen James from Mayer Brown. 14 November 2018